ACCC & ANCO News

The following information has been received by ANCO.


****ACCC NEWS****
The Association of Community Cancer Center's (ACCC) This Week At ACCC was published today and is available online at http://www.accc-cancer.org/mediaroom/newsletters/media_ACCCNEWSLETTER_12-29-2008.html. ANCO is an Institutional Member of ACCC. This edition features:

UnitedHealthcare Changes Requirement Related to Herceptin Coverage

Register Today: March 18-21, 2009, ACCC's 35th Annual National Meeting

FDA Approves Gleevec for New Indication

Welcome Aboard to ACCC's Newest Cancer Program Members

ACCC’s Drug Database and Compendia-Based Drug Bulletin Put on Hold

ACCC's Website to Be Upgraded and Improved

Oncology Review Journal Available Online to ACCC Members

Q&A on ACCC's Listserv: Smoking Cessation, K-ras Testing

ACCC's CE Blackboard: Lung Cancer, Year in Review

Take Our Survey: Oncology Issues and ACCC's Website

State Medical Oncology Societies Host Membership Meetings


****ANCO NEWS****
The Association of Northern California Oncologists (ANCO), Leukemia & Lymphoma Society, & Indiana University present

ASH Highlights 2008
Tuesday, February 10th, 2009; 5:30PM-9:15PM
Hotel Nikko, 222 Mason Street, San Francisco
(415) 394-1111

The Association of Northern California Oncologists was organized in 1990 to be an advocate for, educate, and inform the practicing oncologist and hematologist and represents 363 oncologists and hematologists throughout Northern California and other states.

ASH Highlights 2008 will summarize the major research and treatment advancements presented at December 2008’s ASH Annual Meeting. The program will focus on surgical, radiation, and medical oncology treatment modalities for hematological malignancies. The faculty will place these developments in context as to their immediate clinical utility.

Educational Objectives. At the conclusion of this educational activity, participants were able to:

• Review, summarize, and interpret important clinical results presented at the 2008 ASH Annual Meeting for surgical, radiation, and medical oncologists; oncology nurses; and, other health care professionals.

• Comprehend and implement of changes in treatment for hematological malignancies.

Target Audience. ASH Highlights 2008 has been designed to meet the educational needs of oncologists, oncology nurses, oncology pharmacists, and other health care professionals involved in the care of people with hematological malignancies.

Accreditation Statement and Designation of Credit. This activity was planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Indiana University School of Medicine and the Association of Northern California Oncologists (ANCO). The Indiana University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Indiana University School of Medicine designated this educational activity for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The California Board of Registered Nurses accepts courses approved for AMA PRA Category 1 Credits as meeting the continuing education requirements for renewal.

Disclosure Statement. In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by the Indiana University School of Medicine (IUSM) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, and Planning Committee members participating in an IUSM-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Program Planning Committee. The Physician Course Director for ASH Highlights 2008 is Steven Coutre, M.D., Stanford Univ. Dr. Coutre was assisted by the ANCO Board of Directors (Richard A. Bohannon, M.D., Norman Cohen, M.D., Jeffrey Cronk, M.D., Bradley Ekstrand, M.D., Ellie Guardino, M.D., Ph.D., John A. Keech, Jr., D.O., L. Wayne Keiser, M.D., Primo Lara, Jr., M.D., Daniel P. Mirda, M.D., Bimal J. Patel, M.D., Robert L. Robles, M.D., and Antoine Sayegh, M.D.) and Group and Institutional Member contacts (George Fisher, M.D., David Gandara, M.D., Joseph Mason, M.D., Hope Rugo, M.D., and Margaret Tempero, M.D.) in the selection of the faculty for ASH Highlights 2008..

Content Consultant. The Indiana University School of Medicine content consultant was Larry D. Cripe, M.D., Associate Professor of Hematology/Oncology.

Agenda & Faculty
5:30PM Registration, Exhibits, & Dinner (available through 7:00PM)

6:00PM Welcome, Introductions, & Talks
Richard A. Bohannon, M.D., ANCO President
Steven E. Coutre, M.D., Program Moderator, Stanford Univ.

Leukemia
Bruno Carneiro de Medeiros, M.D., Stanford Univ.

Lymphoma
Joseph Tuscano, M.D., Univ. of California, Davis

Multiple Myeloma
Steven E. Coutre, M.D., Stanford Univ.

Myelodysplastic Syndrome
Jason R. Gotlib, M.D., Stanford Univ.

9:15PM Adjourn

Acknowledgment of Commercial Support. Support for this educational activity is anticipated in part from Alaven, biogenIDEC, Celgene, Cephalon Oncology, Eisai, Enzon Pharmaceuticals, Genentech BioOncology, Genzyme Oncology, GlaxoSmithKline Oncology, Millennium, Ortho Biotech, and possibly others (as of the date of this mailing). The final list of supporters will be available at the meeting.

Download the meeting announcement/registration form at www.anco-online.org/ash.html.